Business Context and Reporting Period
This Form 8-K was filed by Anthem, Inc. (now Elevance Health, Inc.) on February 23, 2016, reporting events occurring on February 18, 2016. The filing addresses corporate governance amendments rather than financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is non-financial in nature.
Material Changes
Effective February 18, 2016, the Board of Directors amended the Company's By-Laws to implement proxy access. Key changes include:
- Addition of Section 1.16 permitting shareholders (or groups of up to 20) owning at least 3% of outstanding common stock continuously for 3 years to nominate director candidates.
- Nominees may constitute up to the greater of 20% of the Board or 2 individuals.
- Updates to Sections 1.5 and 1.6 regarding Advance Notice of Shareholder Business and Nominations to accommodate proxy access.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document focuses solely on the procedural implementation of the By-Law amendments.
Key Facts for Investor Verification
- Verify the specific eligibility requirements for proxy access nominees as detailed in the attached Exhibit 3.2 (Amended By-Laws).
- Confirm the calculation method for the maximum number of proxy access nominees (greater of 20% of the Board or 2 individuals).
- Note that this filing does not impact the Company's financial statements or operational results.